INGREZZA Trademark

Trademark Overview


On Tuesday, August 26, 2025, a trademark application was filed for INGREZZA with the United States Patent and Trademark Office. The USPTO has given the INGREZZA trademark a serial number of 99358616. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 26, 2025. This trademark is owned by Neurocrine Biosciences, Inc.. The INGREZZA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease

Providing medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
ingrezza

General Information


Serial Number99358616
Word MarkINGREZZA
Filing DateTuesday, August 26, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, August 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a sequence of right pointing arrows colored pink on the left shading into orange and the word "INGREZZA". The “ING” is colored pink on the left shading into orange and the “REZZA” is colored purple. The white in the mark is background and is not claimed as a feature.
Goods and ServicesPharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease
Indication of Colors claimedThe color(s) pink, orange, and purple is/are claimed as a feature of the mark.
Goods and ServicesProviding medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 26, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, August 26, 2025NEW APPLICATION ENTERED
Tuesday, August 26, 2025APPLICATION FILING RECEIPT MAILED